Evidence map›Paper›PMID 34414662›Full record

ArticleJournal of cellular and molecular medicine2021

Excitotoxic stimulation activates distinct pathogenic and protective expression signatures in the hippocampus.

Ebru Caba, Marcus D Sherman, Karen L G Farizatto, Britney Alcira, Hsin-Wei Wang, Charles Giardina, Dong-Guk Shin, Conner I Sandefur, Ben A Bahr

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Integrative Transcriptomics and Mendelian Randomization IdentifyCurrent issues in molecular biology · 2026
    Article
  2. Article
  3. Ginseng extract improves synaptic resiliency: A key factor for healthy cognitive aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ebru CabaVertex Pharmaceuticals, Cambridge, MA, USA.
Marcus D ShermanBiotechnology Research and Training Center, University of North Carolina-Pembroke, Pembroke, NC, USA.
Karen L G FarizattoBiotechnology Research and Training Center, University of North Carolina-Pembroke, Pembroke, NC, USA.
Britney AlciraBiotechnology Research and Training Center, University of North Carolina-Pembroke, Pembroke, NC, USA.
Hsin-Wei WangBioinformatics and Biocomputing Institute, University of Connecticut, Storrs, CT, USA.
Charles GiardinaDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA.
Dong-Guk ShinBioinformatics and Biocomputing Institute, University of Connecticut, Storrs, CT, USA.
Conner I SandefurDepartment of Biology, University of North Carolina-Pembroke, Pembroke, NC, USA.
Ben A BahrDepartment of Pharmaceutical Sciences and the Neurosciences Program, University of Connecticut, Storrs, CT, USA.ORCID 0000-0002-8400-4599
University of Connecticut · USUniversity of North Carolina at Pembroke · USUniversity of North Carolina at Chapel Hill · US

Funding

UNCP RISE Option 2R25GM077634 · NIGMS · UNIVERSITY OF NORTH CAROLINA AT PEMBROKE · PI SMITH, RACHEL B. · 2006 to 2021
$4.3M
Strenghtening Research Capacity at UNC PembrokeG11HD052381 · NICHD · UNIVERSITY OF NORTH CAROLINA AT PEMBROKE · PI HOLMES, LEONARD · 2007 to 2011
$485k
Development of Lysosomal Modulatory Drugs to Treat Alzheimer's DiseaseR41AG031590 · NIA · SYNAPTIC DYNAMICS, INC. · PI BAHR, BEN A · 2009 to 2009
$163k
NIA NIH HHS R41 AG031590NICHD NIH HHS G11 HD052381NIGMS NIH HHS R25 GM077634NIH HHS 1G11HD052381NIH HHS 1R41AG031590NIH HHS R25GM077634
6 · The paper itself

Abstract

Excitotoxic events underlying ischaemic and traumatic brain injuries activate degenerative and protective pathways, particularly in the hippocampus. To understand opposing pathways that determine the brain's response to excitotoxicity, we used hippocampal explants, thereby eliminating systemic variables during a precise protocol of excitatory stimulation. N-methyl-d-aspartate (NMDA) was applied for 20 min and total RNA isolated one and 24 h later for neurobiology-specific microarrays. Distinct groups of genes exhibited early vs. delayed induction, with 63 genes exclusively reduced 24-h post-insult. Egr-1 and NOR-1 displayed biphasic transcriptional modulation: early induction followed by delayed suppression. Opposing events of NMDA-induced genes linked to pathogenesis and cell survival constituted the early expression signature. Delayed degenerative indicators (up-regulated pathogenic genes, down-regulated pro-survival genes) and opposing compensatory responses (down-regulated pathogenic genes, up-regulated pro-survival genes) generated networks with temporal gene profiles mirroring coexpression network clustering. We then used the expression profiles to test whether NF-κB, a potent transcription factor implicated in both degenerative and protective pathways, is involved in the opposing responses. The NF-κB inhibitor MG-132 indeed altered NMDA-mediated transcriptional changes, revealing components of opposing expression signatures that converge on the single response element. Overall, this study identified counteracting avenues among the distinct responses to excitotoxicity, thereby suggesting multi-target treatment strategies and implications for predictive medicine.

Indexed as

N-MethylaspartateProtective AgentsAnimalsBrain Injuries, TraumaticGene Expression RegulationHippocampusNF-kappa BRatsRats, Sprague-DawleyNF-kappa BN-MethylaspartateProtective Agentscompensatory signallingexcitotoxic responsegene arrayneuroprotectionrepair pathwaytranscription factor

Identifiers

PMID34414662
PMCPMC8435451
OpenAlexW3193999253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.